Steven J. Fliesler, PhD, SUNY Distinguished Professor and the Meyer H. Riwchun Endowed Chair Professor of ophthalmology, has been awarded a $2.2 million grant from the National Eye Institute of the National Institutes of Health to better understand a rare cause of blindness that strikes young children.
Michael H. Farkas, PhD, assistant professor of ophthalmology, has been awarded a five-year, $1.6 million grant from the National Institutes of Health to study potential treatment strategies for retinitis pigmentosa.
A team led by Mark D. Parker, PhD, assistant professor of physiology and biophysics, has been awarded funding from the National Institutes of Health to study endothelial membrane transport proteins in the cornea.
Vision researchers at the Jacobs School of Medicine and Biomedical Sciences and VA Western New York Healthcare System led a study demonstrating that adding antioxidant therapy to current standard of care prevents vision loss in an animal model of a rare genetic disease.
Steven J. Fliesler, PhD, has been appointed editor-in-chief of Experimental Eye Research and also has received the Dean’s Award in Neuroscience and Ophthalmology from Louisiana State University (LSU) Health Sciences Center New Orleans.
Steven J. Fliesler, PhD, UB Distinguished Professor and Meyer H. Riwchun Endowed Chair Professor of ophthalmology, has been elected to a leadership post in the Association for Research in Vision and Ophthalmology (ARVO).
Surgeons and researchers sharing facilities in UB’s Clinical and Translational Science Institute and Kaleida Health’s Gates Vascular Institute (GVI) is resulting in collaboration, synergy and world-class innovation.
Mark D. Parker, PhD, assistant professor of physiology and biophysics, has received the 2017 Cell and Molecular Physiology Section (CaMPS) New Investigator Award from the American Physiological Society (APS).
At the 2017 Medical Student Research Forum, aspiring physician-scientists showcased 46 original research projects they conducted at the University at Buffalo, its partner health care agencies and institutions nationwide.
Researchers in the Department of Physiology and Biophysics have proposed a single, unifying model for an elusive membrane transport protein involved in a rare hereditary condition that results in vision loss.
Michael H. Farkas, PhD, who joined the Department of Ophthalmology as an assistant professor in July, has been named a 2016 Emerging Vision Scientist by the National Alliance for Eye and Vision Research (NAEVR).
Evan Myers, a candidate in the physiology doctoral program, has been recognized by the American Physiology Society for his research in the area of blindness caused by dysregulated pH homeostasis in the cornea.
John M. Sullivan, MD, PhD, associate professor of ophthalmology, has received three grants totaling over $2.5 million to continue research that could lead to gene therapies for hereditary retinal and macular degenerations.
Aspiring physician-scientists showcased 38 original research projects at the 2016 Medical Student Research Forum. The displays showed work they conducted at the University at Buffalo, its partner health care agencies and institutions nationwide.